Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
The envelope spike of HIV-1 employs a 'glycan shield' to protect itself from antibody-mediated neutralization. Paradoxically, however, potent broadly neutralizing antibodies (bnAbs) that target this shield have been isolated. The unusually high glycan density on the gp120 subunit limits pr...
Main Authors: | Pritchard, L, Spencer, D, Royle, L, Bonomelli, C, Seabright, G, Behrens, A, Kulp, D, Menis, S, Krumm, S, Dunlop, D, Crispin, D, Bowden, T, Scanlan, C, Ward, A, Schief, W, Doores, K, Crispin, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Nature Publishing Group
2015
|
Similar Items
-
HIV-1 glycan density drives the persistence of the mannose patch within an infected individual
by: Coss, K, et al.
Published: (2016) -
Glycan microheterogeneity at the PGT135 antibody recognition site on HIV-1 gp120 reveals a molecular mechanism for neutralization resistance.
by: Pritchard, L, et al.
Published: (2015) -
The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
by: Bonomelli, C, et al.
Published: (2011) -
Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans.
by: Dunlop, D, et al.
Published: (2010) -
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
by: Doores, K, et al.
Published: (2010)